Mirum Pharmaceuticals (MIRM) Change in Inventory (2021 - 2026)

Mirum Pharmaceuticals' Change in Inventory history runs 6 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 28.14% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $7.7 million, a 57.9% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 166.84% from the prior year.
• Change in Inventory retreated to $1.9 million in Q1 2026 per MIRM's latest filing, from $2.3 million in the prior quarter.
• Across five years, Change in Inventory topped out at $2.8 million in Q3 2022 and bottomed at -$1.2 million in Q4 2023.
• The 5-year median for Change in Inventory is $989000.0 (2023), against an average of $1.1 million.
• Across the five-year window, Change in Inventory plunged 220.81% in 2022 and soared 1061.19% in 2023, its largest moves.
• Year by year, Change in Inventory stood at -$598000.0 in 2022, then tumbled by 106.02% to -$1.2 million in 2023, then surged by 117.37% to $214000.0 in 2024, then surged by 966.36% to $2.3 million in 2025, then fell by 15.86% to $1.9 million in 2026.
• Per Business Quant, the three latest MIRM Change in Inventory figures stand at $1.9 million (Q1 2026), $2.3 million (Q4 2025), and $1.2 million (Q3 2025).